Skin Analytics' DERM achieves Class III CE mark
The CE mark allows DERM to independently discharge benign lesions without clinician review, backed by clinical evidence.
See the latest news and media coverage for Skin Analytics. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI dermatology triage and teledermatology platform
skin-analytics.comLast updated
In short: Skin Analytics launched DERM Zero, the world's first Class III CE-marked AI for autonomous skin cancer assessment using only smartphones.
The CE mark allows DERM to independently discharge benign lesions without clinician review, backed by clinical evidence.
It was highlighted as a practical example of AI relieving pressure on NHS dermatology teams.
The AI-powered solution uses Class III medical device technology to deliver clinical-grade skin cancer assessments from a standard smartphone.
First West Yorkshire trust launches AI platform for instant lesion analysis in tele-dermatology service, triaging patients efficiently. Three-year programme includes independent evaluation.
EXCLUSIVE: A mother who dismissed a red mark on her thigh as an insect bite was diagnosed with deadly melanoma after groundbreaking NHS AI technology...
Extensive hospital testing has paved the way for a new digital solution that can detect cancer from home.
The world's first regulated medical device technology approved to autonomously assess skin cancer from a smartphone will be unveiled today at HLTH Europe.
Bradford Teaching Hospitals NHS Foundation Trust has begun using AI with the aim of detecting skin cancer earlier.
Track Skin Analytics and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.